Results 211 to 220 of about 48,469 (263)

Cutaneous T‐cell lymphomas and dupilumab for atopic dermatitis: A systematic review and expert consensus

open access: yesJournal of the European Academy of Dermatology and Venereology, Volume 40, Issue 8, Page 1344-1358, August 2026.
Systematic review (51 studies; 547 patients) indicates dupilumab may unmask/worsen CTCL (mainly MF/SS). A French Delphi consensus recommends rigorous diagnostic workup, avoiding dupilumab in confirmed CTCL, discontinuing upon diagnosis, and favouring methotrexate or phototherapy.
Florent Amatore   +8 more
wiley   +1 more source

Identification of Novel Risk Loci for Common B-Cell Lymphoma Subtypes Through Cross-Trait Analysis with Idiopathic Inflammatory Myopathies. [PDF]

open access: yesCancers (Basel)
Che WI   +7 more
europepmc   +1 more source

Endoscopic findings are associated with histologic types of primary small intestinal lymphoma: a retrospective study in Japan. [PDF]

open access: yesClin Endosc
Kitamura M   +14 more
europepmc   +1 more source

Treatment of Follicular Lymphoma With CHOP and Anti-CD20 Therapy: 15-Year Follow-Up of the SWOG S0016 Trial.

open access: yesJAMA Oncol
Shadman M   +6 more
europepmc   +1 more source

Checkpoint inhibitors, obinutuzumab plus PET-adapted ultra-low dose nodal radiotherapy yield high efficacy in treatment-naïve follicular lymphoma: Results from the phase II 'FLUORO' study. [PDF]

open access: yesBr J Haematol
Martynchyk A   +15 more
europepmc   +1 more source

Successful Multimodal Therapeutic Approach for CD30‐positive Folliculotropic Mycosis Fungoides

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 8, Page e1123-e1125, August 2026.
Chiara L. Blomen   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy